Global Blood Therapeutics Inc. Revenue per Employee (GBT), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Global Blood Therapeutics Inc.  (NASDAQ: GBT)
 

Global Blood Therapeutics's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 50.46% in the second quarter 2022, year on year to cumulative value of $235 million, Global Blood Therapeutics's revenue per employee grew on a trailing twelve months basis to $ 434,928, this marks a new company high.
Within the Healthcare sector Employees of 136 other companies have achieved higher revenue per employee. While Global Blood Therapeutics's total ranking has deteriorated compared to the previous quarter from 0 to 1465. Global Blood Therapeutics has 540 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

GBT Revenue per Employee (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter		 (Sep 30 2021)
III. Quarter		 (Jun 30 2021)
II. Quarter
Y / Y Revenue Change 50.46 % 41.28 % 35.85 % 41.1 % 50.96 %
Sales per Employee (TTM) $ 434,928 390,493 360,646 333,231 305,152
GBT's Total Ranking # 1465 # 0 # 0 # 0 # 0
Seq. Revenue Change 29.71 % -1.67 % 7.77 % 9.46 % 21.8 %

GBT Company Profile >> Back to GBT Efficiency Comparisons >> Compare GBT Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 74
Healthcare Sector # 137
Overall Market # 1465

Revenue per Employee Statistics
High Average Low
$ 434,928 $ 310,729 $ 156,696
(Jun 30 2022)   (Sep 30 2020)



Financial Statements
Global Blood Therapeutics's Revenue MRQ $ 72 Millions Visit GBT's Income Statement
Global Blood Therapeutics's Revenues TTM $ 235 Millions Visit GBT's aggregate revenue growth
What are GBT's Sales? Visit GBT's Sales by Segment




Other Ratios
Global Blood Therapeutics's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
GBT's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for GBT's Competitors
Revenue per Employee for GBT's Suppliers
Revenue per Employee for GBT's Customers

You may also want to know
GBT's Sales Growth Rates GBT's Pe Price to earnings ratio GBT's Receivables Turnover Ratio GBT's Stock Quote
GBT's Net Income Growth Rates GBT's Ps Price to Sales ratio GBT's Sales per Employee GBT's Asset Turnover Ratio
GBT's Net Margin GBT's Pb Price to Book ratio GBT's Financial Strength Ratios GBT's Dividend Payout Ratio
Date modified: 2026-08-30T17:12:36+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2022, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2022Number of Employees Jun 30 2022
Inari Medical Inc   745,844.44 $ 335.630  Million 450 
Enanta Pharmaceuticals Inc  745,150.00 $ 89.418  Million 120 
Xenetic Biosciences Inc   743,796.00 $ 1.488  Million 2 
Merck and Co Inc   742,880.00 $ 55,716.000  Million 75,000 
Heron Therapeutics Inc   741,968.75 $ 94.972  Million 128 
Pacira Biosciences inc   741,034.98 $ 614.318  Million 829 
Cerus Corporation  738,791.67 $ 212.772  Million 288 
Progyny Inc   720,862.15 $ 617.058  Million 856 
Cardiff Lexington Corporation  720,322.44 $ 12.966  Million 18 
Hologic Inc  689,024.05 $ 4,871.400  Million 7,070 
Fulgent Genetics Inc   688,354.17 $ 925.148  Million 1,344 
Chinook Therapeutics Inc   688,037.97 $ 54.355  Million 79 
Ngm Biopharmaceuticals Inc   687,750.00 $ 68.775  Million 100 
Aurinia Pharmaceuticals Inc   686,617.19 $ 87.887  Million 128 
Intra cellular Therapies Inc   685,411.52 $ 138.453  Million 202 
Masimo Corp  683,833.18 $ 1,504.433  Million 2,200 
Sensus Healthcare Inc   682,800.00 $ 40.968  Million 60 
Co diagnostics Inc   680,217.08 $ 78.225  Million 115 
Arcus Biosciences Inc   680,073.21 $ 408.724  Million 601 
Johnson and Johnson  678,892.05 $ 95,588.000  Million 140,800 
Reshape Lifesciences Inc  676,777.78 $ 12.182  Million 18 
Axonics Inc   669,070.77 $ 217.448  Million 325 
Vyne Therapeutics Inc   668,200.00 $ 6.682  Million 10 
Bionexus Gene Lab Corp   649,225.42 $ 12.335  Million 19 
Neurocrine Biosciences Inc   648,400.00 $ 1,296.800  Million 2,000 
Neptune Wellness Solutions Inc   646,951.09 $ 54.991  Million 85 
Acadia Pharmaceuticals Inc   642,106.52 $ 512.401  Million 798 
Organon and Co   635,500.00 $ 6,355.000  Million 10,000 
Ati Physical Therapy Inc   631,891.00 $ 631.891  Million 1,000 
Amicus Therapeutics inc   628,463.80 $ 321.145  Million 511 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.